News
FDA, Pfizer and COVID-19
Digest more
In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal ...
Pfizer said its antibody-drug conjugate Padcev extended survival when combined with the immunotherapy Keytruda in some ...
Pfizer is evaluating the details of the FDA's plan and having discussions with the agency, a Pfizer spokesperson said in a statement to USA TODAY on May 22.
Pfizer's experimental drug to treat sickle cell anemia failed to meet the main goal in a late stage trial, the drugmaker said ...
This story was originally published by ProPublica, a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story ...
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news on drugmaker Pfizer. Trump Says ‘No Deal’ With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results